Investigation of Newly Diagnosed Drug-Naive Patients with Systemic Autoimmune Diseases Revealed the Cleaved Peptide Tyrosine Tyrosine (PYY 3-36) as a Specific Plasma Biomarker of Rheumatoid Arthritis

There is a current imperative to reveal more precisely the molecular pathways of early onset of systemic autoimmune diseases (SADs). The investigation of newly diagnosed drug-naive SAD patients might contribute to identify novel disease-specific and prognostic markers. The multiplex analysis of 30 p...

Descripción completa

Detalles Bibliográficos
Autores principales: Balog, Jozsef A., Kemeny, Agnes, Puskas, Laszlo G., Burcsar, Szilard, Balog, Attila, Szebeni, Gabor J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240466/
https://www.ncbi.nlm.nih.gov/pubmed/34239365
http://dx.doi.org/10.1155/2021/5523582

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240466/
https://www.ncbi.nlm.nih.gov/pubmed/34239365
http://dx.doi.org/10.1155/2021/5523582

Ejemplares similares